HealthEquity, Inc. — Cyborg Score 7/10

Solid
Financial Services / Healthcare Technology

Strategic Profile

HealthEquity holds a dominant market position in the HSA and consumer-directed benefits space, leveraging proprietary technology and an extensive distribution network of health plans, brokers, and benefits administrators. The company's competitive moat is built on scale, regulatory expertise as an IRS-designated non-bank trustee, and integrated advisory services that drive customer engagement and retention.

Cyborg Score Rationale

HealthEquity demonstrates strong market leadership in a growing industry with healthy revenue growth (~20% YoY) and improving profitability. However, the company faces competitive pressures and market headwinds that temper its exceptional positioning.

Top Insights

  • Largest HSA custodian by account volume with non-bank trustee designation creating regulatory moat
  • FY2025 revenue of $1.2B growing ~20% YoY with improving profitability
  • Multi-channel distribution through direct sales and network of brokers, advisors, and plan sponsors
  • Recent FY2027 guidance of $1.38B-$1.41B revenue indicates sustained growth momentum

Named Competitors

  • Ascensus — HSA and retirement account administrator
  • Voya Financial — Benefits and retirement solutions provider
  • ConnectYourCare — Consumer-directed benefits platform

Recent Developments

  • (January 2026) Issued FY2027 revenue guidance of $1.38B-$1.41B and reaffirmed FY2026 guidance
  • (January 2026) Wells Fargo initiated Buy rating on HQY stock
  • (February 2026) Stock trading near $91.81 with market cap of approximately $6.3B

Open the full interactive HealthEquity, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →